The association between knee osteoarthritis and polycystic ovary syndrome in postmenopausal women: preliminary results

被引:3
|
作者
Deniz, A. [1 ]
Kehribar, L. [2 ]
机构
[1] Alanya Alaaddin Keykubat Univ, Dept Obstet & Gynecol, Alanya, Turkey
[2] Samsun Gazi State Hosp, Orthoped Clin, Samsun, Turkey
关键词
Knee osteoarthritis; Polycystic ovary syndrome; BMI; Postmenopause; ESTROGEN REPLACEMENT THERAPY; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; CARTILAGE; INTERLEUKIN-6; PREVALENCE; RISK;
D O I
10.26355/eurrev_202108_26446
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: The comorbidity of many risk factors associated with the etiology of osteoarthritis (OA) and polycystic ovary syndrome (PCOS) is commonly observed. However, to the best of our knowledge, there are no studies in literature on the relationship between PCOS history and knee OA development in postmenopausal women. PATIENTS AND METHODS: A total of 120 postmenopausal women diagnosed with knee osteoarthritis who underwent surgical treatment in our orthopedic clinic and, 80 postmenopausal women who referred to our orthopedic clinic but did not have knee osteoarthritis were randomly included in our study. Body Mass Index (BMI) values, PCOS history and demographic data of the patients in both groups were examined. RESULTS: PCOS was found to be an independent risk factor for OA. PCOS was 2.734 times effective in the development of knee OA, Odd ratio (95% confidence interval) = 2.734 (1.206-6.198) and p-value 0.016. BMI was found to be an independent risk factor for OA. BMI between 25-30 was found to be 2.783 times more effective on knee OA development when compared with BMI<25, Odd Ratio (95% confidence interval) = 2.783 (1.324-5.852) and p-value 0.07. In addition, BMI>30 was found to be 9.237 times more effective on knee OA development when compared with BMI< 25, Odd Ratio (95% confidence interval) = 9.237 (3.992-21.374) and p-value < 0.001. CONCLUSIONS: The history of PCOS was found to be statistically significantly higher in the knee OA group. BMI and PCOS were found to be independent risk factors in the development of knee OA.
引用
收藏
页码:4895 / 4899
页数:5
相关论文
共 50 条
  • [11] Association between Insulin Resistance and Breast Parenchyma in Women with Polycystic Ovary Syndrome
    Sarac, Zeliha Fulden
    Bilgen, Isil
    TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2012, 16 (01) : 1 - 5
  • [12] Statistical Genomic Approach Identifies Association between FSHR Polymorphisms and Polycystic Ovary Morphology in Women with Polycystic Ovary Syndrome
    Du, Tao
    Duan, Yu
    Li, Kaiwen
    Zhao, Xiaomiao
    Ni, Renmin
    Li, Yu
    Yang, Dongzi
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [13] Possible association between circulating CTRP3 and knee osteoarthritis in postmenopausal women
    Maghbooli, Zhila
    Hossein-nezhad, Arash
    Khoshechin, Ghazal
    Niketeghad, Gelare
    Moradi, Shahrokh
    Adabi, Elham
    Malekhosseini, Seyed Ali Asghar
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2019, 31 (07) : 927 - 934
  • [14] Study the relevance between inflammatory factors and estradiol and their association with knee osteoarthritis in postmenopausal women
    Liu, Y. -P.
    Li, J.
    Xin, S. -B.
    Xu, J.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (02) : 472 - 478
  • [15] Possible association between circulating CTRP3 and knee osteoarthritis in postmenopausal women
    Zhila Maghbooli
    Arash Hossein-nezhad
    Ghazal Khoshechin
    Gelare Niketeghad
    Shahrokh Moradi
    Elham Adabi
    Seyed Ali Asghar Malekhosseini
    Aging Clinical and Experimental Research, 2019, 31 : 927 - 934
  • [16] Association of vitamin D, BMD and knee osteoarthritis in postmenopausal women
    Zafeiris, Evangelos P.
    Babis, George C.
    Zafeiris, Christos P.
    Chronopoulos, Efstathios
    JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS, 2021, 21 (04) : 509 - 516
  • [17] Management of polycystic ovary syndrome in postmenopausal women: a medical black hole
    Fenton, Anna
    Panay, Nick
    CLIMACTERIC, 2008, 11 (02) : 89 - 90
  • [18] Gherlin expression in women with polycystic ovary syndrome -: a preliminary study
    Skommer, J
    Katulski, K
    Poreba, E
    Meczekalski, BM
    Slopien, R
    Plewa, R
    Gozdzicka-Józefiak, A
    Warenik-Szymankiewicz, A
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2005, 26 (05) : 553 - 556
  • [19] Association Between Polycystic Ovary Syndrome and Cancer Risk
    Yin, Weiyao
    Falconer, Henrik
    Yin, Li
    Xu, Liangzhi
    Ye, Weimin
    JAMA ONCOLOGY, 2019, 5 (01) : 106 - 107
  • [20] Association between Polycystic Ovary Syndrome and Gut Microbiota
    Guo, Yanjie
    Qi, Yane
    Yang, Xuefei
    Zhao, Lihui
    Wen, Shu
    Liu, Yinhui
    Tang, Li
    PLOS ONE, 2016, 11 (04):